By current evidences, SGLT-2 inhibitors seem to attenuate apoptotic myocardial cells in diabetic cardiomyopathy and MI, however more studies are required to explore their roles on cardiac apoptosis. This evidence concerns the gene SLC5A2 and diabetic cardiomyopathy.